Literature DB >> 22308485

Modeling hepatitis C virus infection using human induced pluripotent stem cells.

Robert E Schwartz1, Kartik Trehan, Linda Andrus, Timothy P Sheahan, Alexander Ploss, Stephen A Duncan, Charles M Rice, Sangeeta N Bhatia.   

Abstract

Human pathogens impact patient health through a complex interplay with the host, but models to study the role of host genetics in this process are limited. Human induced pluripotent stem cells (iPSCs) offer the ability to produce host-specific differentiated cells and thus have the potential to transform the study of infectious disease; however, no iPSC models of infectious disease have been described. Here we report that hepatocyte-like cells derived from iPSCs support the entire life cycle of hepatitis C virus, including inflammatory responses to infection, enabling studies of how host genetics impact viral pathogenesis.

Entities:  

Mesh:

Year:  2012        PMID: 22308485      PMCID: PMC3289320          DOI: 10.1073/pnas.1121400109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Hepatitis C virus replication in transfected and serum-infected cultured human fetal hepatocytes.

Authors:  Catherine A Lázaro; Ming Chang; Weiliang Tang; Jean Campbell; Daniel G Sullivan; David R Gretch; Lawrence Corey; Robert W Coombs; Nelson Fausto
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

2.  Microscale culture of human liver cells for drug development.

Authors:  Salman R Khetani; Sangeeta N Bhatia
Journal:  Nat Biotechnol       Date:  2007-11-18       Impact factor: 54.908

3.  Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I.

Authors:  Rhea Sumpter; Yueh-Ming Loo; Eileen Foy; Kui Li; Mitsutoshi Yoneyama; Takashi Fujita; Stanley M Lemon; Michael Gale
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

4.  Binding of hepatitis C virus to CD81.

Authors:  P Pileri; Y Uematsu; S Campagnoli; G Galli; F Falugi; R Petracca; A J Weiner; M Houghton; D Rosa; G Grandi; S Abrignani
Journal:  Science       Date:  1998-10-30       Impact factor: 47.728

5.  The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

Authors:  Elisa Scarselli; Helenia Ansuini; Raffaele Cerino; Rosa Maria Roccasecca; Stefano Acali; Gessica Filocamo; Cinzia Traboni; Alfredo Nicosia; Riccardo Cortese; Alessandra Vitelli
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

6.  Cellular glycosaminoglycans and low density lipoprotein receptor are involved in hepatitis C virus adsorption.

Authors:  Raphaële Germi; Jean-Marc Crance; Daniel Garin; Josette Guimet; Hugues Lortat-Jacob; Rob W H Ruigrok; Jean-Pierre Zarski; Emmanuel Drouet
Journal:  J Med Virol       Date:  2002-10       Impact factor: 2.327

7.  Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells.

Authors:  Svetlana Marukian; Christopher T Jones; Linda Andrus; Matthew J Evans; Kimberly D Ritola; Edgar D Charles; Charles M Rice; Lynn B Dustin
Journal:  Hepatology       Date:  2008-12       Impact factor: 17.425

8.  Complete replication of hepatitis C virus in cell culture.

Authors:  Brett D Lindenbach; Matthew J Evans; Andrew J Syder; Benno Wölk; Timothy L Tellinghuisen; Christopher C Liu; Toshiaki Maruyama; Richard O Hynes; Dennis R Burton; Jane A McKeating; Charles M Rice
Journal:  Science       Date:  2005-06-09       Impact factor: 47.728

9.  Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry.

Authors:  Matthew J Evans; Thomas von Hahn; Donna M Tscherne; Andrew J Syder; Maryline Panis; Benno Wölk; Theodora Hatziioannou; Jane A McKeating; Paul D Bieniasz; Charles M Rice
Journal:  Nature       Date:  2007-02-25       Impact factor: 49.962

10.  Human occludin is a hepatitis C virus entry factor required for infection of mouse cells.

Authors:  Alexander Ploss; Matthew J Evans; Valeriya A Gaysinskaya; Maryline Panis; Hana You; Ype P de Jong; Charles M Rice
Journal:  Nature       Date:  2009-01-28       Impact factor: 49.962

View more
  100 in total

Review 1.  Human induced pluripotent stem cells--from mechanisms to clinical applications.

Authors:  Katharina Drews; Justyna Jozefczuk; Alessandro Prigione; James Adjaye
Journal:  J Mol Med (Berl)       Date:  2012-05-30       Impact factor: 4.599

2.  Productive Infection of Human Embryonic Stem Cell-Derived NKX2.1+ Respiratory Progenitors with Human Rhinovirus.

Authors:  Robert A Jenny; Claire Hirst; Sue Mei Lim; Adam L Goulburn; Suzanne J Micallef; Tanya Labonne; Anthony Kicic; Kak-Ming Ling; Stephen M Stick; Elizabeth S Ng; Alan Trounson; Antonietta Giudice; Andrew G Elefanty; Edouard G Stanley
Journal:  Stem Cells Transl Med       Date:  2015-04-14       Impact factor: 6.940

3.  Characterization of type I interferon pathway during hepatic differentiation of human pluripotent stem cells and hepatitis C virus infection.

Authors:  Joseph Ignatius Irudayam; Deisy Contreras; Lindsay Spurka; Aparna Subramanian; Jenieke Allen; Songyang Ren; Vidhya Kanagavel; Quoclinh Nguyen; Arunachalam Ramaiah; Kalidas Ramamoorthy; Samuel W French; Andrew S Klein; Vincent Funari; Vaithilingaraja Arumugaswami
Journal:  Stem Cell Res       Date:  2015-08-15       Impact factor: 2.020

4.  Apolipoprotein E codetermines tissue tropism of hepatitis C virus and is crucial for viral cell-to-cell transmission by contributing to a postenvelopment step of assembly.

Authors:  Kathrin Hueging; Mandy Doepke; Gabrielle Vieyres; Dorothea Bankwitz; Anne Frentzen; Juliane Doerrbecker; Frauke Gumz; Sibylle Haid; Benno Wölk; Lars Kaderali; Thomas Pietschmann
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

5.  Induced pluripotent stem cells, form in vitro tissue engineering to in vivo allogeneic transplantation.

Authors:  Yi-Chen Li; Kai Zhu; Tai-Horng Young
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

Review 6.  Human induced pluripotent stem cells derived hepatocytes: rising promise for disease modeling, drug development and cell therapy.

Authors:  Fei Yi; Guang-Hui Liu; Juan Carlos Izpisua Belmonte
Journal:  Protein Cell       Date:  2012-03-22       Impact factor: 14.870

Review 7.  Murine models of hepatitis C: what can we look forward to?

Authors:  Markus von Schaewen; Alexander Ploss
Journal:  Antiviral Res       Date:  2014-01-24       Impact factor: 5.970

8.  Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems.

Authors:  Amir Shlomai; Robert E Schwartz; Vyas Ramanan; Ankit Bhatta; Ype P de Jong; Sangeeta N Bhatia; Charles M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

9.  Organoids as Model for Infectious Diseases: Culture of Human and Murine Stomach Organoids and Microinjection of Helicobacter Pylori.

Authors:  Sina Bartfeld; Hans Clevers
Journal:  J Vis Exp       Date:  2015-11-12       Impact factor: 1.355

Review 10.  Modelling human disease with pluripotent stem cells.

Authors:  Richard Siller; Sebastian Greenhough; In-Hyun Park; Gareth J Sullivan
Journal:  Curr Gene Ther       Date:  2013-04       Impact factor: 4.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.